Michaela C. Baldauf
Munich, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
MondoA drives malignancy in B-ALL through enhanced adaptation to metabolic stress.
Journal: Blood
Published: April 02, 2021
Publisher Correction: Oncogenic hijacking of a developmental transcription factor evokes vulnerability toward oxidative stress in Ewing sarcoma.
Journal: Nature communications
Published: November 24, 2020
High Specificity of BCL11B and GLG1 for EWSR1-FLI1 and EWSR1-ERG Positive Ewing Sarcoma.
Journal: Cancers
Published: February 26, 2020
Cooperation of cancer drivers with regulatory germline variants shapes clinical outcomes.
Journal: Nature communications
Published: February 15, 2019
Targeting the CALCB/RAMP1 axis inhibits growth of Ewing sarcoma.
Journal: Cell death & disease
Published: December 09, 2018
Functional genomics identifies AMPD2 as a new prognostic marker for undifferentiated pleomorphic sarcoma.
Journal: International journal of cancer
Published: September 17, 2018
Systematic identification of cancer-specific MHC-binding peptides with RAVEN.
Journal: Oncoimmunology
Published: April 25, 2018
Are EWSR1-NFATc2-positive sarcomas really Ewing sarcomas?
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: November 13, 2017
Lysosome-associated membrane glycoprotein 1 predicts fratricide amongst T cell receptor transgenic CD8+ T cells directed against tumor-associated antigens.
Journal: Oncotarget
Published: April 18, 2016
Last Updated: 09/26/2026